| Onderneming | Koers | | Verschil (%) | Verschil t.o.v. 1 jan (%) | Kapitalisatie (M$) | Poids |
 | BIOHAVEN PHARMACEUTICAL.. | 18.09 |  | -2.53% | 30.33% | 541 | 8.12% |
 | RELMADA THERAPEUTICS, I.. | 3.79 |  | -4.05% | 8.60% | 114 | 7.83% |
 | SAGE THERAPEUTICS, INC. | 44.81 |  | -3.78% | 17.49% | 2 666 | 7.35% |
 | INTRA-CELLULAR THERAPIE.. | 48.36 |  | 2.31% | -10.68% | 4 580 | 7.17% |
 | MYRIAD GENETICS, INC. | 18.86 |  | -3.73% | 35.01% | 1 528 | 6.54% |
 | JAZZ PHARMACEUTICALS PL.. | 151 |  | -2.27% | -5.22% | 9 508 | 6.52% |
 | BIOGEN INC. | 285.45 |  | -2.05% | 5.24% | 41 105 | 5.86% |
 | UCB | 78.58 |  | 0.90% | 5.87% | 15 872 | 4.47% |
 | NEUROCRINE BIOSCIENCES,.. | 104.49 |  | 0.65% | -12.52% | 10 045 | 4.39% |
 | SAREPTA THERAPEUTICS, I.. | 121.36 |  | 0.47% | -6.34% | 10 653 | 4.33% |